February 11, 2026 11:07 AM
Solid Surge in Dr Reddys Laboratories Ltd Stock Price Today. Dr Reddys Laboratories Ltd Up by 1.08%
Dr Reddys Laboratories Ltd's stock has surged by 1.08%, and it is currently trading at 1269.60. Additionally, the stock maintains a PE ratio of 18.9800, while the industry PE is 32.3330.
February 11, 2026 10:09 AM
Dr Reddys Laboratories Ltd Share Price Performs Strongly Today, Up 1.08%
The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 1.08% boost, with the current market value at 1269.60 per share. This surge has not gone unnoticed by investors.
February 11, 2026 9:09 AM
Real-Time Updates: Dr Reddys Laboratories Ltd Share Price Today
With a remarkable 1.08% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at 1269.60. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.9800, while the industry's PE ratio is 32.3330.
February 11, 2026 8:09 AM
Live Market Updates: Dr Reddys Laboratories Ltd Price Jumps 1.03%
Dr Reddys Laboratories Ltd's stock price surged by 1.03%, reaching the current market value of 1268.90 per share. This surge is a testament to the stock's recent performance.
February 11, 2026 7:09 AM
Dr Reddys Laboratories Ltd in Focus in Today's Trading Session. Stock Rallies 1.19%
Dr Reddys Laboratories Ltd experienced a substantial 1.19% boost in its share price and has garnered significant attention from the market. It's now trading at 1270.90, making it an appealing option for investors.
February 11, 2026 6:09 AM
In a Strong Move, Dr Reddys Laboratories Ltd Jumps 0.88% Today
Dr Reddys Laboratories Ltd's share price rallied by 0.88%, reaching the current market price of 1267.00. This surge is indicative of the stock's recent positive performance.
February 11, 2026 5:08 AM
Solid Jump for Dr Reddys Laboratories Ltd in Today's Trading Session: Share Price Climbs Up by 0.06%
After a significant 0.06% gain, Dr Reddys Laboratories Ltd's shares are now valued at 1256.80 in the current market. This upward movement is attracting attention from both retail and institutional investors.